$6.72
0.17 (+2.60%)
BioScrip, Inc. (NASDAQ:BIOS)
CAPS Rating:
The Company provides pharmaceutical and pharmacy benefit management services.
The Company provides pharmaceutical and pharmacy benefit management services.